-
Pharmacology
-
- Enzymes
-
- ATPase & GTPase
- Carboxylase
- Caspase
- Cholinesterase
- Coenzymes
- Cyclase
- Cyclooxygenase
- Cytochrome P450
- Deacetylase
- Dehydrogenase
- Demethylase
- Hydrolase
- Hydroxylase
- Isomerase
- Kinase
-
- Adenosine kinase
- Akt
- AMP-kinase
- ATM
- Aurora
- CAM Kinase
- Casein kinase
- Chk
- Cyclin-dependent kinase
- DNA-dependent Protein Kinase
- DYRK
- FAK
- General
- Glycogen synthase kinase
- JAK
- MAPK
- mTOR
- Myosin light chain kinase
- PAK
- PI3-kinase
- PIKfyve
- PLK
- Protein Kinase A
- Protein Kinase C
- Protein Kinase G
- Rho kinase
- Sphingosine kinase
- Src
- Tyrosine Kinase
- Ligase
- Oxidases
- Oxygenase
- Phosphatase
- Phosphodiesterase
- Phospholipase & Lipase
- Polymerase & Transcriptase
- Protease
- Reductase
- Secretase
- Synthetase & synthase
- Telomerase
- Transaminase
- Transferase
- Ion Channels
- - Receptors & Transporters
-
- Adenosine
- Adrenoceptors
- Cannabinoid
- Catalytic Receptors
- Chemokine
- Dopamine
- Enzyme-Linked Receptors
- G protein-coupled estrogen
- GABA
- Glutamate
- Glycine
- Histamine
- Imidazoline
- Inositol triphosphate receptor
- Leukotriene & Related
- Lysophospholipid receptor
- Melatonin
- Muscarinic
- Nicotinic
- Nuclear Receptors
- Opioids
- Orphan 7-TM Receptors
- Peptide Receptors
-
- Angiotensin
- Apelin
- AXOR
- Bombesin
- Bradykinin
- CCK
- CRF
- Endothelin
- Galanin
- Ghrelin
- Glucagon and Related Receptors
- LHRH
- Melanocortin
- Melanocyte Stimulating Hormone
- Motilin
- Neuromedin
- Neuropeptide FF/AF Receptors
- Neuropeptide S
- Neuropeptide Y
- Neurotensin
- Orexin
- Other
- Oxytocin
- PAR
- Secretin receptor
- Sensory Neuron Specific Receptor
- Somatostatin
- Substance P
- Tachykinins
- Vasopressin
- VIP
- Platelet-Activating Factor (PAF)
- Prostanoid
- Purinergics
- Serotonin
- Sigma
- Smoothened
- Sphingosine 1-Phosphate Receptors
- TGR5
- Toll-like Receptors
- Transporters
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Epigenetics
- Extracellular matrix & cell adhesion
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
-
Research Area
-
- Addiction
- Alzheimer's Disease
-
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Muscarinic
- Nicotinic
- Nitric oxide signaling
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Cancer
-
- Angiogenesis
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Epigenetics
- Extracellular matrix & cell adhesion
- Nuclear Receptors
- Signal transduction
- Depression
- Diabetes
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Heart disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Calcium
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Hypertension
-
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Obesity
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Serotonin
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Pain & inflammation
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- GABA
- Glutamate
- Histamine
- Immunomodulators
- Nitric oxide signaling
- Opioids
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Parkinson's Disease
- Respiratory disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Histamine
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Schizophrenia
- Stress / Anxiety
- Stroke
-
- Adenosine
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
We have 645 products in: Biochemicals >> Pharmacology >> Receptors & Transporters
Receptor & transporter ligands beginning with A |
| A B - C D - E F - G H - L M - N O - P Q - S T - V W - Z 0 - 9 |
Code | Name | Details | Image Abreview Publication |
|---|---|---|---|
| Highly selective D4 agonist Purity: > 98% |   | ||
| Potent, competitive P2X7 receptor antagonist Purity: > 98% | | ||
| Phytohormone; produced by a variety of cells in humans and animals Purity: > 99% | | ||
| Potent, selective CB1 agonist Purity: > 98% | | ||
| Potent, selective CB1 agonist Purity: > 98% | | ||
| Endogenous neurotransmitter active at acetylcholine receptors | | ||
| CB1 agonist Purity: > 98% | | ||
| Potent, endogenous melanocortin receptor 2 (MC2) agonist Purity: > 98% | | ||
| Selective RARβ and RARγ agonist Purity: > 98% | | ||
| Endogenous P1 receptor agonist Purity: > 99% | | ||
| Dopamine agonist Purity: > 99% | | ||
| M2/M4 antagonist Purity: > 99% | | ||
| M2 antagonist Purity: > 99% |  | ||
| Selective PDGFR tyrosine kinase inhibitor Purity: > 99% | | ||
| Potent, selective EGF receptor tyrosine kinase Purity: > 99% | | ||
| Potent specific PDGF receptor tyrosine kinase inhibitor Purity: > 99% | | ||
| Selective EGF receptor tyrosine kinase inhibitor Purity: > 98% | | ||
| Selective TrkA receptor inhibitor Purity: > 99% | | ||
| EP1 and EP2 antagonist Purity: > 98% | | ||
| Endogenous glycine agonist Purity: > 98% | | ||
| Fluorescent β2 adrenoceptor antagonist Purity: > 97% |  | ||
| CB1 receptor antagonist / inverse agonist Purity: > 99% | | ||
| Anandamide transport inhibitor Purity: > 99% | | ||
| CB2 antagonist / inverse agonist Purity: > 98% | | ||
| Selective retinoic acid receptor α/β (RARα/β) agonist Purity: > 98% | | ||
| Highly selective CXCR4 antagonist Purity: > 99% | | ||
| Fluorescent H2 antagonist Purity: > 97% | | ||
| mGlu7 agonist Purity: > 99% | | ||
| AMPA agonist Purity: > 99% | | ||
| AMPA agonist Purity: > 98% | | ||
| Selective H2 agonist Purity: > 99% | | ||
| Predominant amyloid-β protein fragment Purity: > 95% | | ||
| Toxic amyloid β peptide fragment Purity: > 95% | | ||
| Endogenous cannabinoid Purity: > 98% | | ||
| Inactive analog of anandamide Purity: > 98% | | ||
| Endogenous CB1 agonist Purity: > 98% | | ||
| Endogenous cannabinoid in water soluble emulsion Purity: > 98% | | ||
| Internal standard for anandamide quantification Purity: > 98% | | ||
| Potent nicotinic agonist Purity: > 98% | | ||
| Testosterone precursor. Major endogenous androgen. Purity: > 99% | | ||
| Vasoconstrictor peptide Purity: > 95% | | ||
| AMPA receptor potentiator Purity: > 99% | | ||
| Broad spectrum glutamate antagonist Purity: > 99% | | ||
| Selective group III mGlu agonist Purity: > 99% | | ||
| Broad spectrum glutamate antagonist; water soluble Purity: > 99% | | ||
| NMDA glutamate site antagonist Purity: > 99% | | ||
| NMDA glutamate site antagonist Purity: > 99% | | ||
| NMDA glutamate site antagonist. Water soluble form. Purity: > 99% | | ||
| Selective endogenous apelin receptor (APJ) ligand Purity: > 95% | | ||
| Highly potent, selective endogenous apelin receptor (APJ) agonist Purity: > 95% | | ||
| Endogenous apelin receptor (APJ) agonist Purity: > 95% | | ||
| Endogenous apelin receptor (APJ) agonist Purity: > 95% | | ||
| Potent, selective GABAB agonist Purity: > 98% | | ||
| M2 antagonist Purity: > 99% | | ||
| Potent, selective GPR119 agonist Purity: > 98% | | ||
| Cannabinoid CB1 and CB2 agonist Purity: > 98% | | ||
| ω-6 polyunsaturated fatty acid, precursor of eicosanoids Purity: > 98% | | ||
| Fluorogenic substrate for fatty acid amide hydrolase (FAAH) Purity: > 99% | | ||
| Potent, endogenous CB1 agonist Purity: > 99% | | ||
| Endogenous cannabinoid agonist Purity: > 95% | | ||
| T-type Ca2+ channel blocker. Endogenous GLYT2 inhibitor. Purity: > 98% | | ||
| Muscarinic receptor agonist Purity: > 99% | | ||
| Partial dopamine D2 agonist Purity: > 99% | | ||
| Potent CB1 and TRPV1 agonist Purity: > 98% | | ||
| Multiple receptor antagonist. Anti-psychotic agent. Purity: > 99% | | ||
| β1 adrenoceptor antagonist Purity: > 99% | | ||
| Selective β1 adrenoceptor antagonist Purity: > 98% | | ||
| Selective α2 adrenergic receptor antagonist Purity: > 99% | | ||
| P2 receptor agonist. Signalling molecule. Purity: > 99% | | ||
| Activates PPARα and PPARγ. Modulates estrogen receptors Purity: > 98% | | ||
| PAR4 agonist peptide Purity: > 95% | |